Novo Nordisk missed its diversity targets last year, and its CEO paid a financial priceRyan Hogg

Novo Nordisk’s CEO took a $1.5 million pay cut in 2024 as the pharma giant’s share price tanked and it missed profit and DEI targets. Read More Novo Nordisk’s CEO took a $1.5 million pay cut in 2024 as the pharma giant’s share price tanked and it missed profit and DEI targets.